Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
IDEAYA Biosciences
What AI says about IDEAYA Biosciences
IDEAYA Biosciences is dedicated to the discovery and development of transformative therapies for cancer, utilizing precision medicine approaches. Their focus is on synthetic lethality and antibody-drug conjugates, aiming to improve clinical outcomes for patients through tailored treatments based on genetic drivers of disease.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Products & Services
Synthetic Lethality Therapeutics
A pipeline of targeted therapies designed to exploit synthetic lethality in cancer cells, focusing on genetic alterations to improve treatment efficacy.
Antibody-Drug Conjugates (ADCs)
Innovative therapies that combine antibodies with cytotoxic drugs to selectively target and kill cancer cells.
Common Questions
What is synthetic lethality?
Synthetic lethality occurs when the loss of function of two genes leads to cancer cell death, while the loss of either gene alone does not affect cell viability.
What types of cancers does IDEAYA target?
IDEAYA focuses on genetically-defined cancers, particularly those with specific mutations such as GNAQ, GNA11, and MTAP gene deletions.
What is the goal of IDEAYA's therapies?
The goal is to develop more selective and effective precision oncology therapies that can alter the course of disease and improve clinical outcomes for cancer patients.